Status:
COMPLETED
Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")
Lead Sponsor:
ANM Adaptive Neuromodulation GmbH
Collaborating Sponsors:
CERES GmbH
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Confirmation of efficacy and safety of acoustic CR®-neuromodulation for the treatment of chronic tinnitus patients using the CE marked ANM T30 CR®-system in a real life outpatient setting. * Identifi...
Eligibility Criteria
Inclusion
- Main
- symptomatic subjective tonal chronical (\> 3 months) tinnitus
- \<60dB hearing loss
- men and women ≥18 years old
- Main
Exclusion
- serious neurologic
- psychiatric or internistic disease
- objective tinnitus
- Morbus Menière
- craniomandibular triggered tinnitus
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01435317
Start Date
November 1 2011
End Date
July 1 2014
Last Update
July 11 2014
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. med. Mueller
Augsburg, Germany, 86167
2
Dr. med. Jan Loehler
Bad Bramstedt, Germany, 24576
3
Praxisverbund Berlin
Berlin, Germany, 10119
4
Dr. med. Daniel Osterland
Berlin, Germany, 10711